Log In
Print
BCIQ
Print
Print this Print this
 

CNTO 6785

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionHuman HuCAL antibody
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat active rheumatoid arthritis (RA)
Regulatory Designation

Partner

MorphoSys AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today